Connection

Prabhakar Baliga to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Prabhakar Baliga has written about Alemtuzumab.
Prabhakar Baliga
Connection Strength
0.143
Alemtuzumab
  1. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.